Henry C. Barry, MD, MS

Balancing needs and risks as the opioid pendulum swings

The CDC encourages clinicians to find a balance of the potential benefits and harms and to avoid inflexibility.

I would have hoped for something better than merely clearing amyloid for my aunt.

What we know about long COVID appears to be following the early course of its parent illness.

It is our longitudinal relationships with patients that allow us to plant seeds and reap the benefits over time.

Author:: Ambar Kulshreshtha, MD, PhD; Summer Sizemore, PharmD; Henry C. Barry, MD, MS

Here is the latest evidence on the efficacy and safety of treatments that are FDA approved or authorized, in clinical trials, or not recommended...

Author:: Mark H. Ebell, MD, MS; Henry C. Barry, MD, MS; David C. Slawson, MD; And Allen F. Shaughnessy, PharmD

Author:: Mark H. Ebell, MD, MS; Henry C. Barry, MD, MS; David C. Slawson, MD; Allen F. Shaughnessy, PharmD

Author:: Nancy E. Kreher, MEd; John M. Hickner, MD, MS; Henry C. Barry, MD, MS; Stephen R. Messimer, PA

Author:: Henry C. Barry, MD, MS; Mark H. Ebell, MD, MS; John Hickner, MD, MS